COYA
Coya Therapeutics, Inc. - Common Stock (COYA)
$81
About Coya Therapeutics, Inc. - Common Stock (COYA)
Coya Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing proprietary new therapies to enhance the function of regulatory T cells. Its pipeline includes Treg Modifying Biologics, Allogeneic Treg-Derived Exosomes, and Autologous Treg Cell Therapy. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Details
Daily high
$3.14
Daily low
$2.72
Price at open
$3.03
52 Week High
$6.62
52 Week Low
$2.72
Market cap
72.3M
Dividend yield
-
Volume
315,216
Avg. volume
169,794
P/E ratio
-3.08
Coya Therapeutics, Inc. - Common Stock News
Details
Daily high
$3.14
Daily low
$2.72
Price at open
$3.03
52 Week High
$6.62
52 Week Low
$2.72
Market cap
72.3M
Dividend yield
-
Volume
315,216
Avg. volume
169,794
P/E ratio
-3.08